CELLULAR THERAPEUTICS LIMITED
48 GRAFTON STREET, MANCHESTER M13 9XX- Active
- Private Limited Company
- Company No. 10931123
- Last Updated: 01 Mar 2024
Company Profile
CELLULAR THERAPEUTICS LIMITED was incorporated on Thursday, August 24, 2017 as a Private Limited Company with registered address in MANCHESTER. CELLULAR THERAPEUTICS LIMITED has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 7 years 5 months and 30 days.
| Name | CELLULAR THERAPEUTICS LIMITED |
|---|---|
| Company number | 10931123 |
| Company type | Private Limited Company |
| Incorporation date | 24 Aug 2017 |
| Status | Active |
| Industry (SIC 2007) |
Address
| Registered Address |
48 GRAFTON STREET MANCHESTER M13 9XX |
|---|---|
| Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
| Name | Nature of Control |
|---|---|
| Immetacyte Limited Grafton Street, M13 9XX |
Dates: Monday, February 26, 2018 - Tuesday, November 19, 2019
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
|
| Dr Neill Moray Mackenzie Nationality: British |
Dates: Thursday, August 24, 2017 - Monday, February 26, 2018
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
|
Accounts and Confirmation
| Type of accounts | DORMANT |
|---|---|
| End of financial Year | 31 August |
| Next annual accounts due | 31 May 2024, (-268 days left) |
| Latest accounts | 31 August 2022 |
| Next confirmation statement due | 21 September 2018 |
| Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against CELLULAR THERAPEUTICS LIMITED.
Previous Names
| Name | Change Date |
|---|---|
| CELLULAR THERAPEUTICS LIMITED | 24 Aug 2017 |
| IMMETACYTE LIMITED | 29 Mar 2018 |